Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial

To compare the efficacy and safety of ziprasidone versus clozapine in patients with psychotic symptoms in Parkinson disease. A 4-week, randomized, single-blind, open-label, parallel comparison of ziprasidone and clozapine was completed. Sixteen patients with Parkinson disease were included. Psychosi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical neuropharmacology 2012-03, Vol.35 (2), p.61-66
Hauptverfasser:	Pintor, Luis, Valldeoriola, Francesc, Baillés, Eva, Martí, María José, Muñiz, Armando, Tolosa, Eduard
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Antipsychotic Agents - therapeutic use Clinical trials Clozapine Clozapine - therapeutic use Cognitive ability Drugs Female Follow-Up Studies Humans Leukocytes Levodopa Male Movement disorders Neurodegenerative diseases Parkinson Disease - complications Parkinson Disease - drug therapy Parkinson Disease - psychology Parkinson's disease Piperazines - therapeutic use Psychosis Psychotic Disorders - complications Psychotic Disorders - drug therapy Psychotic Disorders - psychology SAP protein Side effects Single-Blind Method Statistics Thiazoles - therapeutic use Treatment Outcome ziprasidone
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!